Interferon production by lymphocytes from patients with systemic lupus erythematosus.
D000974:Antibodies, Antinuclear / Q000032:analysis; D003165:Complement System Proteins / Q000032:analysis; D003588:Cytopathogenic Effect, Viral; D005260:Female; D006511:Hepatitis B Antigens / Q000032:analysis; D006801:Humans; D005779:Immunodiffusion; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007372:Interferons / Q000096:biosynthesis*; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology*; D010222:Parainfluenza Virus 1, Human / Q000276:immunology; D012217:Rheumatoid Factor / Q000032:analysis
D000974:Antibodies, Antinuclear; D006511:Hepatitis B Antigens; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D003165:Complement System Proteins; D007372:Interferons; D012217:Rheumatoid Factor